Skip to main content

Table 1 Correlations between circLIFRSA expression and clinical characteristics

From: CircLIFRSA/miR-1305/PTEN axis attenuates malignant cellular processes in non-small cell lung cancer by regulating AKT phosphorylation

Parameters

 

Expression of circLIFRSA

P value

 

Cases

High

Low

Age

   

0.1083

 ≤55

11

8

3

 

 >55

63

28

35

 

Gender

   

0.1067

 Male

44

18

26

 

 Female

30

18

12

 

Lesion location

   

0.3074

 Right

49

24

25

 

 Left

23

10

13

 

 Bilateral

2

2

0

 

BMI

   

0.0833

 <22

36

16

20

 

 ≥22

38

20

18

 

Smoking history

   

0.7899

 Yes

32

15

17

 

 No

42

21

21

 

Tumor size(cm)

   

0.0381*

 <2

46

27

19

 

 ≥2

28

9

19

 

Numbers of tumor

   

0.0438*

 Solitary

64

28

36

 

 Multiple

10

8

2

 

Metastasis

   

0.7115

 Yes

8

3

5

 

 No

66

33

33

 

TNM stage

   

0.0564

 I/II

66

35

31

 

 III/IV

8

1

7

 

Differentiation grade

   

0.005**

 High

39

25

14

 

 Low

35

11

24

 

Pathological type

  

0.0144*

 Squamous carcinoma

25

7

18

 

 Adenocarcinoma

45

28

17

 

 Other type

4

1

3

 

Serum CYFRA21-1

   

0.12

 ≤3.3

49

27

22

 

 >3.3

25

9

16

 

CA199

   

0.3511

 >35

70

33

37

 

 ≥35

4

3

1

 

CA125

   

0.3575

 >35

68

35

33

 

 ≥35

6

1

4

 
  1. *P < 0.05, ** P < 0.01